Hong Kong Med J 13:485–489PubMed Talazoparib 55. Demiralp B, Ilgan S, Ozgur KA, Cicek EI, Yildrim D, Erler K (2007) Bilateral femoral insufficiency fractures treated with inflatable intramedullary nails: a case report. Arch Orthop Trauma Surg 127:597–601CrossRefPubMed 56. Lee P, van der Wall H, Seibel MJ (2007) Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis

on alendronate therapy. J Endocrinol Investig 30:590–597 57. Sayed-Noor AS, Sjoden GO (2008) Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy—a case report. Acta Orthop 79:565–567CrossRefPubMed 58. Odvina CV, Levy S, Rao S, Zerwekh JE, Sudhaker RD (2009) Unusual mid-shaft fractures during long term bisphosphonate therapy. Clin Endocrinol (Oxf) 72:161–168CrossRef 59. Ali T, Jay RH (2009) Spontaneous femoral shaft fracture after long-term alendronate. Age Ageing 38:625–626CrossRefPubMed 60. Goddard MS, Reid KR, Johnston JC, Khanuja HS (2009) Atraumatic bilateral femur fracture in long-term bisphosphonate use. Orthopedics 32:607. doi:10.​3928/​01477447-20090624-27 CrossRef 61. Sayed-Noor AS, Sjoden GO (2009) Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res 467:1921–1926CrossRefPubMed 62. Cermak K, Shumelinsky F, Alexiou J, Lonafarnib research buy Gebhart

MJ (2009) Case reports: Sapitinib nmr subtrochanteric femoral stress fractures after prolonged alendronate therapy. Clin Orthop Relat Res 468:1991–1996CrossRefPubMed 63. Bush LA, Chew FS (2009) Subtrochanteric femoral insufficiency fracture in woman on bisphosphonate therapy for glucocorticoid-induced osteoporosis. Radiol Case Rep 4. doi:1.​2484/​rcr.​v4i1.​261 64. Lee JK (2009) Bilateral atypical femoral diaphyseal aminophylline fractures in a patient treated with alendronate sodium. Int J Rheum Dis 12:149–154CrossRefPubMed 65. Edwards MH, McCrae FC, Young-Min SA (2010)

Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side? Osteoporos Int 21:701–703CrossRefPubMed 66. Schilcher J, Aspenberg P (2009) Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop 80:413–415CrossRefPubMed 67. Abrahamsen B, Eiken P, Eastell R (2009) Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 24:1095–1102CrossRefPubMed 68. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85:4118–4124CrossRefPubMed 69.